Pathogenesis of Rosacea

Cosmetic Dermatology

Volumn 21, Issue 4, 2008, Pages 224-232

  Reszko, Anetta E ^a   Granstein, Richard D ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70350002793     PISSN: 10413766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol. 2002;46:584-587.
2. Plewig G, Jansen T, Kligman AM. Pyoderma faciale: a review and report of 20 additional cases: is it rosacea? Arch Dermatol. 1992;128:1611-1617. (Pubitemid 23001178)
3. Wilkin JK. Rosacea: pathophysiology and treatment. Arch Dermatol. 1994;130:359-362. (Pubitemid 24107876)
4. Rebora A. Rosacea. J Invest Dermatol. 1987;88(suppl 3):56S-60S.
5. Dahl M V. Pathogenesis of rosacea. Adv Dermatol. 2001;17:29-45.
6. Crawford GH, Pelle MT, James WD. Rosacea: I. etiology, pathogenesis, and subtype classification. J Am Acad Dermatol. 2004;51:327-341. (Pubitemid 39178655)
7. Jansen T, Plewig G. Rosacea: classification and treatment. J R Soc Med. 1997;90:144-150. (Pubitemid 27135946)
8. Berg M, Liden S. An epidemiological study of rosacea. Acta Derm Venereol. 1989;69:419-423. (Pubitemid 19226109)
9. Borrie P. Rosacea with special reference to its ocular manifestations. Br J Dermatol. 1953;65:458-463.
10. Quarterman MJ, Johnson D W, Abele DC, et al. Ocular rosacea: signs, symptoms, and tear studies before and after treatment with doxycycline. Arch Dermatol. 1997;133:49-54. (Pubitemid 27044305)
11. Akpek EK, Merchant A, Pinar V, et al. Ocular rosacea: patient characteristics and follow-up. Ophthalmology. 1997;104:1863-1867. (Pubitemid 28100343)
12. Valanconny C, Michel JL, Gain P, et al. Ocular rosacea [in French]. Ann Dermatol Venereol. 1999;126:450-454.
13. Starr PA. Oculocutaneous aspects of rosacea. Proc R Soc Med. 1969;62:9-11.
14. Bamford JT. Rosacea: current thoughts on origin. Semin Cutan Med Surg. 2001;20:199-206. (Pubitemid 32927782)
15. Zug KA, Palay DA, Rock B. Dermatologic diagnosis and treatment of itchy red eyelids. Surv Ophthalmol. 1996;40:293-306. (Pubitemid 26046207)
16. Jancin B. UV exposure and gender unrelated to rosacea risk: new findings go against common beliefs. Skin & Allergy News. 2007;38(10):1, 8.
17. Yazici AC, Tamer L, Ikizoglu G, et al. GSTM1 and GSTT1 null genotypes as possible heritable factors of rosacea. Photodermatol Photoimmunol Photomed. 2006;22:208-210. (Pubitemid 44089000)
18. Marks R. Concepts in the pathogenesis of rosacea. Br J Dermatol. 1968;80:170-177.
19. Rebora A. The red face: rosacea. Clin Dermatol. 1993;11:225-234. (Pubitemid 23191689)
20. Nunzi E, Rebora A, Hamerlinck F, et al. Immunopathological studies on rosacea. Br J Dermatol. 1980;103:543-551. (Pubitemid 11243277)
21. Sibenge S, Gawkrodger DJ. Rosacea: a study of clinical patterns, blood flow, and the role of Demodex folliculorum. J Am Acad Dermatol. 1992;26:590-593.
22. Marks R, Harcourt-Webster JN. Histopathology of rosacea. Arch Dermatol. 1969;100:683-691.
23. Neumann E, Frithz A. Capillaropathy and capillaroneogenesis in the pathogenesis of rosacea. Int J Dermatol. 1998;37:263-266. (Pubitemid 28189686)
24. Lim HH, Buttery JE. Determination of ethanol in serum by an enzymatic PMS-INT colorimetric method. Clin Chim Acta. 1977;75:9-12. (Pubitemid 8030852)
25. Talwar HS, Griffiths CE, Fisher GJ, et al. Reduced type I and type III procollagens in photodamaged adult human skin. J Invest Dermatol. 1995;105:285-290.
26. Borrie P. The state of the blood vessels of the face in rosacea. II. Br J Dermatol. 1955;67:73-75.
27. Borrie P. The state of the blood vessels of the face in rosacea. I. Br J Dermatol. 1955;67:5-8.
28. Wilkin JK. Why is flushing limited to a mostly facial cutaneous distribution? J Am Acad Dermatol. 1988;19(2 pt 1):309-313.
29. Lewis VJ, Holme SA, Wright A, et al. Rosacea fulminans in pregnancy. Br J Dermatol. 2004;151:917-919. (Pubitemid 39482132)
30. Wilkin JK. Effect of subdepressor clonidine on flushing reactions in rosacea: change in malar thermal circulation index during provoked flushing reactions. Arch Dermatol. 1983;119:211-214. (Pubitemid 13151962)
31. Wilkin JK. Oral thermal-induced flushing in erythematotelangiectatic rosacea. J Invest Dermatol. 1981;76:15-18. (Pubitemid 11173530)
32. Brinnel H, Friedel J, Caputa M, et al. Rosacea: disturbed defense against brain overheating. Arch Dermatol Res. 1989;281:66-72. (Pubitemid 19064143)
33. Powell FC, Corbally N, Powell D. Substance P and rosacea. J Am Acad Dermatol. 1993;28:132-133.
34. Seiffert K, Ding W, Wagner JA, et al. ATPgammaS enhances the production of inflammatory mediators by a human dermal endothelial cell line via purinergic receptor signaling. J Invest Dermatol. 2006;126:1017-1027.
35. Chen X, Niyonsaba F, Ushio H, et al. Synergistic effect of antibacterial agents human beta-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli. J Dermatol Sci. 2005;40:123-132. (Pubitemid 41446209)
36. Niyonsaba F, Nagaoka I, Ogawa H. Human defensins and cathelicidins in the skin: beyond direct antimicrobial properties. Crit Rev Immunol. 2006;26:545-576.
37. Niyonsaba F, Ogawa H. Protective roles of the skin against infection: implication of naturally occurring human antimicrobial agents beta-defensins, cathelicidin LL-37 and lysozyme. J Dermatol Sci. 2005;40:157-168. (Pubitemid 41728963)
38. Barak O, Treat JR, James WD. Antimicrobial peptides: effectors of innate immunity in the skin. Adv Dermatol. 2005;21:357-374. (Pubitemid 41826758)
39. Yamasaki K, Di Nardo A, Bardan A, et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med. 2007;13:975-980. (Pubitemid 47222043)
40. Jay H. Rosacea: molecular insights. Skin and Aging. 2007;15(9):14-15.
41. Gürer MA, Erel A, Erbas D, et al. The seroprevalence of Helicobacter pylori and nitric oxide in acne rosacea. Int J Dermatol. 2002;41:768-770. (Pubitemid 35422841)
42. Gürakan F, Kocak N, Yüce A. Helicobacter pylori serology in childhood. Turk J Pediatr. 1996;38:329-334. (Pubitemid 126537729)
43. Sharma VK, Lynn A, Kaminski M, et al. A study of the prevalence of Helicobacter pylori infection and other markers of upper gastrointestinal tract disease in patients with rosacea. Am J Gastroenterol. 1998;93:220-222. (Pubitemid 29063971)
44. Rebora A, Drago F, Picciotto A. Helicobacter pylori in patients with rosacea. Am J Gastroenterol. 1994;89:1603-1604.
45. Utas S, Ozbakir O, Turasan A, et al. Helicobacter pylori eradication treatment reduces the severity of rosacea. J Am Acad Dermatol. 1999;40:433-435. (Pubitemid 29115304)
46. Bamford JT, Tilden RL, Blankush JL, et al. Effect of treatment of Helicobacter pylori infection on rosacea. Arch Dermatol. 1999;135:659-663. (Pubitemid 29277833)
47. Rufli T, Büchner SA. T-cell subsets in acne rosacea lesions and the possible role of Demodex folliculorum. Dermatologica. 1984;169:1-5. (Pubitemid 14083507)
48. Rufli T, Mumcuoglu Y. The hair follicle mites Demodex folliculorum and Demodex brevis: biology and medical importance: a review. Dermatologica. 1981;162:1-11. (Pubitemid 11154578)
49. Rufli T, Mumcuoglu Y, Cajacob A, et al. Demodex folliculorum: aetiopathogenesis and therapy of rosacea and perioral dermatitis [in German]. Dermatologica. 1981;162:12-26. (Pubitemid 11154579)
50. Forton F, Seys B. Density of Demodex folliculorum in rosacea: a case-control study using standardized skin-surface biopsy. Br J Dermatol. 1993;128:650-659. (Pubitemid 23172024)
51. Bonnar E, Eustace P, Powell FC. The Demodex mite population in rosacea. J Am Acad Dermatol. 1993;28:443-448. (Pubitemid 23075260)
52. Georgala S, Katoulis AC, Kylafis GD, et al. Increased density of Demodex folliculorum and evidence of delayed hypersensitivity reaction in subjects with papulopustular rosacea. J Eur Acad Dermatol Venereol. 2001;15:441-444. (Pubitemid 33040117)
53. Marks R. Histogenesis of the inflammatory component of rosacea. Proc R Soc Med. 1973;66:742-745.
54. Grosshans E, Dungler T, Kien TT, et al. Demodex folliculorum and rosacea: experimental and immunological studies [in German]. Z Hautkr. 1980;55:1211-1218. (Pubitemid 11232955)
55. Forton F. Demodex and perifollicular inflammation in man: review and report of 69 biopsies [in French]. Ann Dermatol Venereol. 1986;113:1047-1058. (Pubitemid 17229358)
56. Ramelet AA, Perroulaz G. Rosacea: histopathologic study of 75 cases [in French]. Ann Dermatol Venereol. 1988;115:801-806.
57. Ayres S Jr, Ayres S III. Demodectic eruptions (demodicidosis) in the human: 30 years' experience with 2 commonly unrecognized entities: pityriasis folliculorum (Demodex) and acne rosacea (Demodex type). Arch Dermatol. 1961;83:816-827.
58. Amichai B, Grunwald MH, Avinoach I, et al. Granulomatous rosacea associated with Demodex folliculorum. Int J Dermatol. 1992;31:718-719.
59. Erbagci Z, Ozgöztasi O. The significance of Demodex folliculorum density in rosacea. Int J Dermatol. 1998;37:421-425. (Pubitemid 28284868)
60. Robinson T W. Demodex folliculorum and rosacea: a clinical and histological study. Arch Dermatol. 1965;92:542-544.
61. Aronson IK, Rumsfield JA, West DP, et al. Evaluation of topical metronidazole gel in acne rosacea. Drug Intell Clin Pharm. 1987;21:346-351. (Pubitemid 17060493)
62. Lowe NJ, Henderson T, Millikan LE, et al. Topical metronidazole for severe and recalcitrant rosacea: a prospective open trial. Cutis. 1989;43:283-286. (Pubitemid 19088750)
63. Persi A, Rebora A. Metronidazole and Demodex folliculorum. Acta Derm Venereol. 1981;61:182-183. (Pubitemid 11147578)
64. Buechner SA. Rosacea: an update. Dermatology. 2005;210:100-108. (Pubitemid 40463198)
65. Baima B, Sticherling M. Demodicidosis revisited. Acta Derm Venereol. 2002;82:3-6. (Pubitemid 34450535)
66. Lübbe J, Stucky L, Saurat JH. Rosaceiform dermatitis with follicular Demodex after treatment of facial atopic dermatitis with 1% pimecrolimus cream. Dermatology. 2003;207:204-205.
67. Bernard LA, Cunningham BB, Al-Suwaidan S, et al. A rosacea-like granulomatous eruption in a patient using tacrolimus ointment for atopic dermatitis. Arch Dermatol. 2003;139:229-231. (Pubitemid 36216271)
68. Oztas MO, Balk M, Ogüs E, et al. The role of free oxygen radicals in the aetiopathogenesis of rosacea. Clin Exp Dermatol. 2003;28:188-192. (Pubitemid 36459629)
69. Guzman-Sanchez DA, Ishiuji Y, Patel T, et al. Enhanced skin blood flow and sensitivity to noxious heat stimuli in papulopustular rosacea. J Am Acad Dermatol. 2007;57:800-805. (Pubitemid 47553073)
70. Lonne-Rahm S, Nordlind K, Edström D W, et al. Laser treatment of rosacea: a pathoetiological study. Arch Dermatol. 2004;140:1345-1349. (Pubitemid 39473634)
71. Minson CT, Berry LT, Joyner MJ. Nitric oxide and neurally mediated regulation of skin blood flow during local heating. J Appl Physiol. 2001;91:1619-1626. (Pubitemid 32900352)